Skip to content
Screener

Xilio Therapeutics, Inc. XLO Q4 2025 Annual earnings

Reported March 23, 2026 · Before market open

Revenue$13.7MBeat by $2.8M
EPS-$0.85Beat by $0.83
Revenue estimate$10.9M
EPS estimate-$1.68

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$4.8M
EPS estimate-$0.82

FAQ

When did Xilio Therapeutics, Inc. report Q4 2025 earnings?
Xilio Therapeutics, Inc. (XLO) reported Q4 2025 earnings on March 23, 2026 before market open.
What were Xilio Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Xilio Therapeutics, Inc. reported revenue of $13.7M and eps of $-0.85 for Q4 2025.
Did Xilio Therapeutics, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $10.9M by $2.8M. EPS beat the consensus estimate of $-1.68 by $0.83.
How did Xilio Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 694.1% from $1.7M a year earlier and eps declined 325.0% from $-0.20.
Where can I find Xilio Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-118544) and the 10-K periodic report (0001193125-26-118550) directly on SEC EDGAR. The filing index links above go to sec.gov.